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CCC- and WASH-mediated endosomal sorting
of LDLR is required for normal clearance of
circulating LDL
Paulina Bartuzi1, Daniel D. Billadeau2,3, Robert Favier4, Shunxing Rong5, Daphne Dekker1, Alina Fedoseienko1,
Hille Fieten4, Melinde Wijers1, Johannes H. Levels6, Nicolette Huijkman1, Niels Kloosterhuis1,
Henk van der Molen1, Gemma Brufau7, Albert K. Groen7, Alison M. Elliott8, Jan Albert Kuivenhoven1,
Barbara Plecko9,10, Gernot Grangl9, Julie McGaughran11,12, Jay D. Horton5,13, Ezra Burstein13,14, Marten H. Hofker1
& Bart van de Sluis1
The low-density lipoprotein receptor (LDLR) plays a pivotal role in clearing
atherogenic circulating low-density lipoprotein (LDL) cholesterol. Here we show that the
COMMD/CCDC22/CCDC93 (CCC) and the Wiskott–Aldrich syndrome protein and SCAR
homologue (WASH) complexes are both crucial for endosomal sorting of LDLR and for its
function. We ﬁnd that patients with X-linked intellectual disability caused by mutations in
CCDC22 are hypercholesterolaemic, and that COMMD1-deﬁcient dogs and liver-speciﬁc
Commd1 knockout mice have elevated plasma LDL cholesterol levels. Furthermore, Commd1
depletion results in mislocalization of LDLR, accompanied by decreased LDL uptake.
Increased total plasma cholesterol levels are also seen in hepatic COMMD9-deﬁcient mice.
Inactivation of the CCC-associated WASH complex causes LDLR mislocalization, increased
lysosomal degradation of LDLR and impaired LDL uptake. Furthermore, a mutation in the
WASH component KIAA0196 (strumpellin) is associated with hypercholesterolaemia in
humans. Altogether, this study provides valuable insights into the mechanisms regulating
cholesterol homeostasis and LDLR trafﬁcking.
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V
arious transmembrane proteins in the endosomal
compartment depend on the Wiskott–Aldrich syndrome
protein and SCAR homologue (WASH) complex to ﬁnd
their appropriate destination in the cell1–3. This pentameric
protein complex, which consists of WASH1, FAM21, strumpellin,
KIAA1033 (also known as SWIP) and CCDC53, is recruited to
endosomes by the retromer complex2,4–6. Retromer is formed by
the vacuolar protein-sorting (VPS) proteins VPS26, VPS29 and
VPS35, and in concert with sorting nexins, it selectively mediates
endosomal cargo sorting into recycling and retrieval pathways7.
Recently, the COMMD/CCDC22/CCDC93 (CCC) complex has
been identiﬁed to interact and colocalize with retromer and the
WASH complex2,8,9. The CCC complex consists of the copper
metabolism MURR1 domain-containing (COMMD) proteins,
coiled-coil domain-containing protein 22 (CCDC22), coiled-coil
domain-containing protein 93 (CCDC93) and C16orf62 (ref. 8).
Among the 10 COMMD proteins10, COMMD1, a gene product
that is mutated in Bedlington terriers affected by a hepatic copper
storage disorder resulting in copper toxicosis11, was shown to
regulate in concert with the WASH complex the recycling of the
copper transporter ATP7A (ref. 8). In this same study, we
reported that X-linked intellectual disability (XLID) patients
carrying a mutation in CCDC22 (c.49A4p.T17A) also have
aberrant copper homeostasis, as serum copper and serum
ceruloplasmin levels are increased in these patients8.
Given the pleiotropic function of COMMD1 (ref. 12) and
CCDC22 (refs 2,8,9,13,14), and the large number of membrane
proteins sorted by the WASH complex3, it is expected that the
CCC complex is involved with numerous physiological processes.
Here we identify that the CCC complex regulates the level
of circulating low-density lipoprotein (LDL) cholesterol by
mediating the endosomal trafﬁcking of the low-density
lipoprotein receptor (LDLR). Mutations affecting the formation
of the CCC complex cause hypercholesterolaemia in humans,
dogs and mice. We further show that LDLR is an endosomal
cargo of the CCC-associated WASH complex, and inactivation of
this complex results also in LDLR mislocalization and impaired
LDL uptake. This study provides novel insights into the molecular
mechanism causing hypercholesterolaemia, and highlights the
importance of CCC and WASH complexes in cholesterol
homeostasis.
Results
CCDC22 mutations are associated with hypercholesterolaemia.
On further clinical analysis of a large XLID family affected with a
CCDC22 p.T17A mutation we discovered that these patients also
have an increase in total plasma cholesterol and LDL cholesterol
levels (Table 1 and Supplementary Fig. 1a), exceeding the 95th
percentile corrected for age and gender15,16. One of the patients
(V-2, 4 years of age) is too young, and plasma cholesterol levels
are not informative in this case17. In another XLID family with a
CCDC22 mutation (p.Y557C) (ref. 18), we found that the
circulating total cholesterol (TC) and LDL cholesterol of the
two patients carrying the mutation were also above the 95th
percentile (Table 1 and Supplementary Fig. 1b). These
observations suggest that mutations in the CCC component
CCDC22 are causally related to hypercholesterolaemia.
COMMD1 deﬁciency results in hypercholesterolaemia in dogs.
Since CCDC22 mutation (p.T17A) and COMMD1 inactivation
both impairs the formation of a stable CCC complex8,13, we were
prompted to investigate the plasma cholesterol levels in dogs with
a COMMD1 loss-of-function mutation11,19. In addition to the
expected copper accumulation in the liver of these animals
(Supplementary Fig. 2a), the levels of the CCC components
CCDC22 and CCDC93 were markedly reduced in liver
homogenates from a COMMD1-deﬁcient (COMMD1 / ) dog
(Fig. 1a). Importantly, similar to patients with CCDC22mutations,
COMMD1 / dogs have elevated plasma TC levels, showing a
B50% increase in plasma cholesterol levels (Fig. 1b) without
affecting plasma triglyceride (TG) concentrations (Fig. 1c). In
unaffected littermates (COMMD1þ / dogs), cholesterol is
predominantly carried in high-density lipoprotein (HDL), due to
the absence of cholesteryl ester transfer protein activity in dogs20.
In COMMD1 / dogs, the plasma cholesterol proﬁle revealed
that cholesterol is mainly present in the very low-density
lipoprotein (VLDL) and LDL fractions (Fig. 1d).
High levels of copper in the liver have previously been
described to be associated with reduced circulating cholesterol
levels in mice21, we therefore evaluated a possible correlation
between progressive hepatic copper accumulation and plasma
cholesterol levels in dogs. As a model, we used Labrador retrievers
Table 1 | Plasma lipid levels of individuals with mutations in CCDC22.
Family Patient DOB Age
CCDC22
Total
cholesterol
HDL LDL TG
a III-1 25/1/67 48 T17A 7.2 mmol l–1 1.1 mmol l–1 5.6 mmol l–1 1.1 mmol l–1
IV-4 27/8/84 30 T17A 6.7 mmol l–1 ND 5.4 mmol l–1 ND
IV-5 28/9/88 26 WT/T17A 5.3 mmol l–1 0.9 mmol l–1 3.5 mmol l–1 1.7 mmol l–1
V-1 18/1/05 9 T17A 5.8 mmol l–1 2.8 mmol l–1 3.9 mmol l–1 0.3 mmol l–1
V-2 9/7/10 4 T17A 4.4 mmol l–1 1.6 mmol l–1 2.5 mmol l–1 0.7 mmol l–1
V-3 6/9/04 10 T17A 7.2 mmol l–1 2.1 mmol l–1 4.9 mmol l–1 0.4 mmol l–1
b I-1 11/6/75 40 WT 5.2 mmol l–1 1.3 mmol l–1 3.5 mmol l–1 1.3 mmol l–1
I-2 6/3/77 38 WT/Y557C 4.9 mmol l–1 1.1 mmol l–1 3.5 mmol l–1 1.1 mmol l–1
II-1 14/7/96 19 Y557C 5.7 mmol l–1 1.6 mmol l–1 4.2 mmol l–1 0.7 mmol l–1
II-2 26/8/03 11 Y557C 6.0 mmol l–1 2.0 mmol l–1 3.9 mmol l–1 0.7 mmol l–1
III-3 25/9/98 16 WT 3.9 mmol l–1 1.4 mmol l–1 2.2 mmol l–1 1.0 mmol l–1
Genotype
DOB, date of birth; ND, not determined.
In red levels 495th percentiles corrected for age and gender. The age is indicated at the moment of clinical evaluation.
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affected by copper toxicosis22,23 (Supplementary Fig. 2b). The
aetiology of this disorder is unknown, but COMMD1 has been
excluded to be the causal gene. Plasma cholesterol levels and
lipoprotein proﬁle were unchanged in affected Labrador retrievers
(Supplementary Fig. 2c,d). These observations are in agreement
with a recent study on Wilson disease, the main disorder of
copper toxicosis in humans24. Although Wilson disease patients
accumulate copper to toxic levels in their livers, as COMMD1-
deﬁcient dogs, no unusual plasma cholesterol (total, HDL and
LDL) levels were observed24. Altogether, these data suggest that
aberrant copper homeostasis and elevated plasma cholesterol
are not causally linked in dogs or humans, and thus the CCC-
deﬁcient phenotype is due to pleiotropic effects.
Ablation of hepatic Commd1 increases plasma LDL in mice.
LDL is the foremost cholesterol type that is elevated in patients
and dogs carrying mutations affecting the CCC complex, and
since the liver is the main organ involved in clearing circulating
LDL cholesterol25 we determined the cholesterol levels and the
lipoprotein proﬁles of hepatocyte-speciﬁc Commd1 knockout
mice (Commd1DHep) (ref. 26) fed either a chow diet or a high-fat
high-cholesterol (HFC, cholesterol 0.2%) diet. Consistent with the
increased plasma cholesterol concentrations found in COMMD1-
deﬁcient dogs, plasma cholesterol levels in Commd1DHep mice
were signiﬁcantly higher than in Commd1loxP/loxP wild-type
(WT) littermates (Fig. 2a), with an increase of B35% (chow-fed
mice) and B39% (HFC-fed mice). Plasma TG levels, hepatic
cholesterol, hepatic TG concentrations and body weight were
however unaffected by the loss of hepatic Commd1 (Fig. 2b and
Supplementary Tables 1 and 2). As shown previously26, hepatic
copper concentrations were not affected in Commd1DHep mice
when dietary copper was not increased (Supplementary Tables 1
and 2), which further supports that the increase in plasma
cholesterol by CCC insufﬁciency is not caused by aberrant copper
homeostasis. These data are in agreement with the fact that
patients with CCDC22 mutations have increased serum
ceruplasmin and copper levels, but do not exhibit clinical signs
of copper overload or liver injury8. In addition, we observed no
differences in cholesterol levels between WT mice and transgenic
mice expressing Cre recombinase in hepatocytes (Alb-Cre), thus
excluding the possibility that Cre recombinase expression in
murine liver affects cholesterol metabolism (Supplementary
Fig. 3a).
Next, we determined the lipoprotein proﬁles of pooled plasma
samples fromWT and Commd1DHep mice fed either conventional
chow (Fig. 2c) or HFC diet (Fig. 2d). Independent of the diet,
hepatic Commd1 ablation resulted in signiﬁcantly higher LDL
cholesterol levels (Fig. 2c–f and Supplementary Fig. 3b,c,d,e).
To assess whether the increase in plasma LDL in hepatocyte
COMMD1-deﬁcient mice is caused by aberrant VLDL home-
ostasis, VLDL production and secretion were measured. As
shown in Supplementary Fig. 4a,b, no differences were found in
VLDL production and secretion, indicating that COMMD1 is not
involved in VLDL homeostasis. Furthermore, we observed no
alterations in hepatic expression of genes and proteins involved
in cholesterol uptake, synthesis or efﬂux (Fig. 2g,h and
Supplementary Fig. 4c). However, consistent with results from
COMMD1-deﬁcient dogs (Fig. 1a), CCDC22 and CCDC93 levels
were both markedly decreased in Commd1-ablated hepatocytes
(Fig. 2g,h). With the notion that all members of the COMMD
family can associate with the CCC complex8,13,14, we assessed
if COMMD9 is also involved in cholesterol homeostasis.
We therefore deleted Commd9 speciﬁcally in hepatocytes by
intravenous injection of recombinant adenovirus carrying Cre
recombinase (Ad-Cre) in conditional Commd9 knockout mice
(Commd9loxP/loxP) (ref. 14). As a negative control mice were
injected with adenovirus carrying the LacZ gene (Ad-LacZ). Cre-
mediated ablation of Commd9 resulted in a clear reduction in
hepatic Commd9 mRNA and COMMD9 protein levels
(Supplementary Fig. 5a,b). Similarly, as shown in hepatocytes
lacking COMMD1 (Fig. 2g,h), hepatic COMMD9 inactivation
resulted in a decrease in CCDC22 and CCDC93 protein levels
(Supplementary Fig. 5b), which was accompanied by an increase
in plasma cholesterol levels (Supplementary Fig. 5c). Together,
these data indicate that mutations affecting the formation of the
CCC complex cause hypercholesterolaemia.
COMMD1 binds to LDLR through its COMM domain. Plasma
LDL cholesterol levels are largely dependent on functional LDL
receptors in the liver, and since the CCC complex mediates
the trafﬁcking of various transmembrane proteins12,14, we
investigated whether COMMD1 interacts with LDLR and
is required for normal LDLR function. Pull-down and
immunoprecipitation assays demonstrated a clear association
between COMMD1 and LDLR (Fig. 3a,b). Immunoﬂuorescence
staining in mouse embryonic ﬁbroblasts (MEFs) and continuous
sucrose gradient fractionation of fresh liver homogenates showed
overlap in the cellular distribution of COMMD1 and LDLR,
which support a physical association between COMMD1 and
LDLR (Fig. 3c,d and Supplementary Fig. 6a). We found that this
COMMD1–LDLR interaction depends on the NPxY-based
trafﬁcking motif within the cytoplasmic tail of LDLR and on
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Figure 1 | COMMD1-deﬁcient dogs are hypercholesterolaemic. (a) Western blot analysis of COMMD1, CCDC22 and CCDC93 in livers from an
unaffected dog (COMMD1þ /þ ) and an affected dog homozygous for a loss-of-function mutation in COMMD1 (COMMD1 / ). (b) Plasma TC and
(c) TG levels of dogs heterozygous (þ / ) (n¼ 5) or homozygous ( / ) (n¼4) for a COMMD1 mutation (d) FPLC lipoprotein proﬁle of COMMD1þ /
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the COMM domain of COMMD1 (Fig. 3e and Supplementary
Fig. 6b). Although additional studies are needed to determine
whether the interaction between COMMD1 and LDLR is direct,
our results are consistent with previous studies, which
demonstrated that the NPxY motif is essential for the binding
of various LDLR adaptor proteins involved in the intracellular
trafﬁcking of LDLR27.
WASH components colocalize and interact with LDLR.
Our prior work demonstrated that the CCC complex acts in
conjunction with the multi-subunit WASH complex to mediate
the trafﬁcking of ATP7A (ref. 8), and this motivated us to assess
the cellular distribution of the WASH complex and retromer
relative to LDLR. Isopycnic centrifugation of murine liver lysates
showed a marked overlap in the cellular distribution of LDLR
with WASH components (WASH1 and FAM21), as well as with
CCC components (CCDC22 and COMMD1), and to a lesser
extent with the retromer component VPS35 (Fig. 3d). Further-
more, immunoprecipitation assays revealed that WASH1 and
FAM21 can both bind to LDLR, but no physical association was
detected between VPS35 and LDLR (Fig. 3f). In addition, the
interaction between the PDZ-domain-containing sortin nexin 27
(SNX27) and LDLR was assessed as SNX27 is required for
retrieval and recycling of numerous transmembrane proteins,
including several members of the LDLR family (for example,
VLDLR)28. However, no interaction of LDLR and SXN27 was
observed (Fig. 3f). Furthermore, the subcellular localization of
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SNX27 and its binding to FAM21 was not affected by COMMD1
deﬁciency (Supplementary Fig. 7). These observations suggest
that the COMMD1-containing CCC complex acts in concert with
the WASH complex to regulate LDLR endosomal trafﬁcking.
COMMD1 and WASH facilitate LDLR trafﬁcking. Next, we
examined whether COMMD1 deﬁciency alters the subcellular
localization of LDLR. As observed in HeLa cells8,
immunoﬂuorescence staining of COMMD1, WASH1 and
VPS35 demonstrated marked overlap in MEFs (Supplementary
Fig. 8). In normal MEFs, LDLR is present in early endosomes, in
EAA1þ and VPS35þ subdomains, as well as, to some extent,
in LAMP1þ lysosomes. Loss of COMMD1 decreased the
colocalization of LDLR with the early endosomal marker EEA1
and the lysosomal marker LAMP1, but increased LDLR
localization to a VPS35-enriched endosomal compartment
(Fig. 4a,b and Supplementary Fig. 9a), suggesting that LDLR
might not be able to trafﬁc normally from retromer-coated
endosomes to other compartments. Next, we quantiﬁed surface
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levels of LDLR in WT and Commd1 / MEFs by using a surface
biotinylation assay. Although total LDLR levels were not affected
by the loss of COMMD1, cell surface levels of LDLR were
markedly reduced (Fig. 4c,d). Decreased levels of LDLR was not
only observed in Commd1 / MEFs but also in primary
hepatocytes isolated from Commd1DHep mice (Supplementary
Fig. 9b,c). To assess the functional effect of LDLR mislocalization
and decreased LDLR surface levels on LDL cellular uptake, we
added ﬂuorescently labelled LDL (Dil-LDL) to the medium and
determined the level of endocytosed LDL. We observed a B40%
decrease in LDL uptake in Commd1 / MEFs compared with
WT cells (Fig. 4e). To evaluate whether COMMD1 deﬁciency
only affects LDL uptake, we also measured the uptake of labelled
transferrin by the transferrin receptor (TfnR). Although the
intracellular trafﬁcking of TfnR shows many similarities to LDLR
trafﬁcking29, no differences in transferrin uptake were observed
between Commd1 / and WT cells (Fig. 4e). Altogether, these
data indicate that COMMD1 is essential for maintaining proper
levels of LDLR within the plasma membrane to clear LDL
cholesterol.
Since the COMMD1-containing CCC complex is recruited to
the endosomes by the WASH complex8, we assessed the
contribution of the WASH complex on LDLR trafﬁcking by
determining the subcellular localization of LDLR in WASH1-
deﬁcient (Wash1 / ) MEFs. Wash1 ablation destabilizes the
entire WASH complex30, and in WASH-deﬁcient MEFs the
colocalization of LDLR and COMMD1 with VPS35, EEA1 and
LAMP1 was increased (Fig. 5a–c and Supplementary Fig. 10).
In addition, removal of WASH resulted in collapsed endosomal
structures, as shown previously30. Although COMMD1 levels
were not affected by WASH deﬁciency, LDLR protein levels were
markedly reduced (Fig. 5d), but were restored by the treatment
with the lysosome inhibitor baﬁlomycin A (Fig. 5e,f), as shown
for epidermal growth factor receptor levels in WASH-deﬁcient
cells30. In addition to a reduction in total LDLR levels (Fig. 5d),
LDLR levels at the cell surface were decreased in Wash1 /
MEFs, as demonstrated by a surface biotinylation assay
(Fig. 5g,h). To assess whether mislocalization and reduced
levels of LDLR in Wash1 / cells affect LDL uptake, Dil-LDL
was added to the media. Dil-LDL uptake was visualized by
microscopy and subsequently quantiﬁed. WASH1 depletion
markedly diminished LDL cellular uptake (Fig. 5i,j). It has been
demonstrated that WASH-mediated actin polymerization on the
endosomal membrane is crucial for endosomal sorting of speciﬁc
cargos, and loss of WASH1 results in endosomal collapse (Fig. 5a)
(ref. 30). Indeed, restoring WTWASH1 in WASH1-deﬁcient cells
rescued the accumulation of LDLR in collapsed endosomes,
which could not be prevented by expressing WASH1-DVCA,
a deletion mutant that cannot activate the Arp2/3 complex
(Supplementary Fig. 11). Altogether, these results indicate that
WASH-mediated F-actin polymerization on endosomes is
essential for the endosomal trafﬁcking of LDLR.
A homozygous splice site mutation in KIAA0196, which
encodes the WASH component strumpellin, causes Ritscher–
Schinzel/3C syndrome (RSS) in a Canadian cohort31. This
mutation results in a 60% reduction in strumpellin levels31,
and RSS patients share many clinical features with patients with
CCDC22 mutations, described thus far18,31. We assessed the
plasma cholesterol levels of one molecularly conﬁrmed RSS
patient (age 25), and found that the KIAA0196 mutation was also
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associated with elevated plasma TC and LDL cholesterol levels
exceeding the 95th percentile corrected for age and gender
(TC¼ 6.5mmol l 1, HDL¼ 1.5mmol l 1, LDL¼ 4.4mmol l 1
and TG¼ 1.2mmol l 1), comparable to the cholesterol increase
seen in patients with CCDC22 mutations (Table 1). These data
indicate that both the CCC and WASH complexes regulate
homeostasis of circulating cholesterol through intracellular
trafﬁcking of LDLR.
Discussion
The LDL–LDLR axis is a potential therapeutic target for lowering
atherogenic plasma cholesterol32, and the intracellular route of
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LDLR has been well described33. However, the mechanisms
regulating the trafﬁcking of LDLR are not completely
understood34. Here we identiﬁed that the multi-subunit protein
complexes CCC and WASH are required for LDLR endosomal
sorting and for directing the receptor to the plasma membrane
(Fig. 6). Mutations affecting the formation of these complexes
are causally related to hypercholesterolaemia in humans, dogs
and mice.
COMMD1 was initially identiﬁed as a regulator of copper
homeostasis in mammals11,26; however, here we uncover that
COMMD1 is also critically important in cholesterol homeostasis.
According to our previous work revealing that COMMD1 and the
CCC complex regulate the endosomal sorting of the copper
transporter ATP7A (ref. 8), we found that this same system
similarly regulates the endosomal trafﬁcking of LDLR. We
demonstrated this in a variety of cellular models, and the
physiologic importance of our observations has been
substantiated in two independent mammalian models of
COMMD1 deﬁciency, which display increased plasma LDL
cholesterol. In agreement with these models, deleterious human
mutations in CCDC22 (refs 8,13,18) are causally linked to
elevated plasma total and LDL cholesterol levels in affected
patients. The atherogenic lipoprotein phenotype of these patients
is similar to that of patients with familial hypercholesterolaemia
caused by heterozygous LDLR mutations35, but cholesterol levels
do not reach the high levels seen in patients with homozygous
mutations in either LDLR, ARH (autosomal recessive hyper-
cholesterolaemia) or APOB (apolipoprotein B), or in patients with
a gain-of-function mutation in PCSK9 (proprotein convertase
subtilisin/kexin type 9) (ref. 35). In addition, elevated TC and
LDL cholesterol levels were found in a RSS patient, with a
homozygous mutation in the KIAA0196 gene31—encoding for a
component of the WASH complex—thus indicating that WASH
dysfunction might also cause aberrant cholesterol homeostasis.
Therefore, mutations in the VPS35 gene associated with
Parkinson’s disease36,37, and in components of the WASH
complex, which are linked to autosomal recessive intellectual
disability, and spastic paraplegia38–40, warrant future attention
with regards to their effects on cholesterol homeostasis.
In endosomal cargo sorting WASH mediates the F-actin
formation on endosomes (Fig. 6) (ref. 3), whereas the CCC
complex is likely involved in cargo recognition, in which the
composition of the CCC complex deﬁnes which cargo is
speciﬁcally sorted. This line of thought is reinforced by the
observation that all 10 members of the COMMD family can
engage in the CCC complex13,41, and by our recent work showing
that the trafﬁcking of Notch, another cargo of this system, is
particularly dependent on COMMD9 in various cell lines14.
Although these observations advocate for the presence of CCC
subcomplexes in cargo selectively trafﬁcking, here we found that
deletion of Commd9 in hepatocytes also causes increased plasma
cholesterol in mice, which indicates that the composition of these
subcomplexes and their roles in cargo trafﬁcking are likely cell
type speciﬁc. Further research is therefore warranted to dissect
the contribution of the COMMD proteins in cargo selectively
trafﬁcking.
The retromer–WASH-associated SNX27 (ref. 42) interacts with
the NPxY-based trafﬁcking motif43, and here we assessed whether
SNX27 is engaged in CCC/WASH-mediated LDLR trafﬁcking. In
agreement with prior work28, we did not ﬁnd SNX27 in the
interactome of LDLR. Furthermore, ablation of COMMD1 did
not affect SNX27–FAM21 interaction or subcellular localization
of SNX27. Our results and the ﬁndings of Steinberg et al.28
showing that the depletion of SNX27 in HeLa cells does not affect
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the levels of LDLR on the cell surface—as shown for other
members of the LDLR family—indicate that it is unlikely that
SNX27 is involved in LDLR trafﬁcking. Interestingly, the SNX27
family member SNX17 has been identiﬁed as an adaptor of
LDLR. Like COMMD1, SNX17 binds to the NPxY motif of
LDLR44–47 and promotes LDLR endocytosis44. SNX17 and
COMMD1 both colocalize to vesicles positive for the early
endosome marker EEA1 (refs 12,44), but in contrast to
COMMD1, localization studies did not demonstrate overlap
between SNX17 and LDLR44. Therefore, we hypothesize that the
action of SNX17 on LDLR trafﬁcking precedes CCC- and
WASH-mediated endosomal sorting of LDLR (Fig. 6). In
addition to SNX17, N-myc downstream regulated gene 1
(NDGR1) also regulates the trafﬁcking of LDLR48. Loss of
NDRG1 reduces LDLR levels on the cell surface accompanied by
impaired LDL uptake. In addition, cells deﬁcient for NDRG1
display accumulation of inducible degrader of the LDLR
(IDOL)-mediated ubiquitinated LDLR in multivesicular bodies,
whose structure is deformed by NDRG1 deﬁciency (Fig. 6)
(ref. 48). Whether CCC and WASH complexes are functionally
connected to the aforementioned proteins or to other regulators
of the LDLR recycling34 warrants further investigation.
Altogether, this study uncovers CCC and WASH as novel
multi-subunit protein complexes in the endosomal trafﬁcking
of LDLR, and provides valuable insights in the molecular
mechanism of cholesterol homeostasis.
Methods
Human studies. All participating patients and their family members consented to
the evaluations performed. Their participation in this study was approved by the
appropriate institutional review boards (Women’s and Children’s Health Network,
Adelaide, South Australia, Australia and Medical University Graz, Graz, Austria),
as previously reported13,31.
Animals. All animal studies were approved by the Institutional Animal Care
and Use Committee, University of Groningen (Groningen, the Netherlands).
Hepatocyte-speciﬁc Commd1 knockout mice (Commd1DHep)26 were backcrossed
for more than eight generations in a C57BL/6J background. All mice were
individually housed males, fed ad libitum with either a standard rodent chow diet
(RMH-B, AB Diets, the Netherlands) or, starting at 8–9 weeks of age, a HFC diet
(45% calories from butter fat) containing 0.2% cholesterol (SAFE Diets), n¼ 6–8.
HFC feeding lasted for 20 weeks. Commd9loxP/loxP mice14 were retro-orbitally
injected with puriﬁed 1 1011 Ad-Cre or Ad-LacZ virus particles49. Mice were
killed following a 4-h morning fasting period. Tissues for mRNA and protein
expression analysis were snap frozen in liquid nitrogen and stored at  80 C until
further analysis. Blood was drawn by heart puncture, and plasma was isolated by
centrifugation at 3,000 r.p.m. for 10min at 4 C.
Dog samples were partly originated from earlier studies19,22. Client owned
Labrador retrievers were admitted to the Department of Clinical Sciences of
Companion Animals, Faculty of Veterinary Medicine, Utrecht University (Utrecht,
the Netherlands). Ultrasound-guided liver biopsies were obtained for diagnostic
purposes from dogs under general anaesthesia. Copper concentrations in liver
biopsies were measured using instrumental neutron activation analysis. Serum
samples that were obtained for diagnostic purposes from Labrador retrievers were
used for the current study, after informed consent was obtained from the owners.
The procedures were approved by Utrecht University Ethical Committee, as
required under Dutch legislation.
Cholesterol and TG analysis in plasma and liver homogenates. TC levels were
determined using colorimetric assay (11489232, Roche Molecular Biochemicals)
with cholesterol standard FS (DiaSys Diagnostic Systems) as a reference. TG levels
were determined using Trig/GB kit (1187771, Roche Molecular Biochemicals) with
Roche Precimat Glycerol standard (16658800) as a reference.
Hepatic lipid extraction. Liver homogenates prepared as 15% (w/v) solutions in
PBS were subjected to lipid extraction according to the Bligh & Dyer method50. In
short, 600 ml of demi-water was mixed with 200ml of liver homogenate, and 3ml of
chloroform/methanol was added and mixed. After 30min of incubation 1.2ml of
H2O and 1ml of chloroform were added, mixed and subsequently centrifuged
(10min, 1,500 r.p.m. at room temperature). The chloroform layer was transferred
into a new glass tube, and was evaporated using nitrogen at 50 C. Lipids were
resolved in 1ml of chloroform and used for further determination of cholesterol
and TG content.
In vivo VLDL-TG production. The experiment was performed on 10- to 13-week-
old chow-fed mice. After a 4-h morning fasting, animals were intraperitoneally
injected with poloxamer 407 (BASF) solution in saline (1 g per kg body weight).
Blood was drawn by retro-orbital puncture at the following time points: 0, 30, 60,
120 and 240min. These samples were used for TG determination and calculation of
VLDL-TG production rate.
Antibodies. In the experimental procedures described, the following antibodies
were used: rabbit polyclonal antibody against COMMD1 (11938-1-AP, Proteintech
Group, 1:1,000); rabbit polyclonal antibody against LDLR (PAB8804, Abnova,
1:1,000); rabbit polyclonal antibody against GST (Z-5) (sc-459, Santa Cruz
Biotechnology, 1:5,000); goat anti-rabbit IgG (Hþ L)-horseradish peroxidase
(HRP) conjugate (170-6515, Bio-Rad Laboratories, 1:10,000); goat anti-mouse
IgG (Hþ L)-HRP conjugate (170-6516, Bio-Rad Laboratories, 1:10,000); mouse
anti-b-actin (A5441, Sigma-Aldrich, 1:5,000); rabbit anti-tubulin (AB4047, Abcam,
1:2,000); rabbit anti-Rab11 (700184, Invitrogen, 1:1,000); rabbit anti-EEA-1
(AB2900, Abcam, 1:1,000); rabbit anti-CCDC22 (16636-1-AP, Proteintech,
1:2,000); and rabbit anti-CCDC93 (20861-1-AP, Proteintech, 1:5,000). Rabbit
polyclonal antibodies against WASH1, FAM21 and VPS35 were previously
described1,5. Anti-apoB100 (1:1,000) and rabbit anti-apoA1 (1:1,000) antibodies
were a gift from A.K. Groen. Rabbit polyclonal antibody against ARH (1:1,000)
was a gift from H.H. Hobbs. Densitometry analysis of western blot bands was
performed using Image Lab 3.0.1 software (Bio-Rad Laboratories). Images have
been cropped for presentation. Full-size images are presented in Supplementary
Fig. 12.
Expression constructs. The following vectors were used in the experiments
described: pEBB-COMMD1-Flag; pEBB-GST; pEBB-COMMD1-GST; pEBB-1-
118-GST; and pEBB-119-190-GST10,51. Full-length Flag-tagged LDLR receptor,
GST-LDL cytoplasmic tail (-cyt) and GST-LDL-cyt Y807A were obtained from
N. Freedman52, and Flag-LDLR was subcloned into pDNA3.1. WT and mutant
WASH1-GFP constructs have been described before30.
Immunoﬂuorescence staining. Staining was carried out as previously described1.
Cells were ﬁxed in ice-cold ﬁxative (4% paraformaldehyde and 0.5% glutaraldehyde
in PBS) and incubated for 18min at room temperature in the dark, followed by
permeabilization with 0.2% Triton X-100 in PBS for 4min. Cells were then
cultured with primary antibodies in IF buffer (TBS plus human serum cocktail)
overnight at 4 C in a humidiﬁer chamber. Next day, cells were washed three times
in PBS, and cells were incubated with secondary antibodies in blocking buffer for
1 h at room temperature. After four washes in PBS and addition of Hoechst 33342
nuclear stain, coverslips were rinsed in water and afﬁxed to slides with Slowfade
Antifade reagent (Invitrogen). Images were obtained with an LSM-710 laser
scanning confocal microscope with a  100/1.4 Oil Plan-Aprochromat objective
lens using ZEN software (Carl Zeiss). Quantitative Pearson’s correlation
coefﬁcients were obtained using Zen 2009 software (Carl Zeiss) by drawing a
region of interest around the objects. The following antibodies were used: rabbit
polyclonal antibody against LDLR (PAB8804, Abnova, 1:200); mouse monoclonal
antibody against COMMD1 (MAB7526, R&D Systems, 1:400); rabbit polyclonal
antibody against EEA1 (2411, Cell Signaling Technologies, 1:250); goat polyclonal
antibody against VPS35 (ab10099-100, Abcam, 1:1,000); rat monoclonal antibody
against LAMP1 (553792, BD Biosciences, 1:500); rabbit polyclonal antibody against
WASH1 (1:1,000); and rabbit polyclonal antibody against FAM21 (1:1,000) (ref. 1).
Gene expression analysis. Pieces of murine liver ofB100mg were homogenized
in 1ml QIAzol Lysis Reagent (Qiagen, Venlo, the Netherlands). Total RNA was
isolated by chloroform extraction. Isopropanol-precipitated and ethanol-washed
RNA pellets were dissolved in RNase-/DNase-free water. RNA (1 mg) was used to
prepare cDNA with the Quantitect Reverse Transcription Kit (Qiagen), according
to the manufacturer’s protocol. cDNA (20 ng) was used for subsequent quantitative
real-time PCR analysis using iTaq SYBR Green Supermix with ROX (Bio-Rad
Laboratories BV) and 7900HT Fast Real-Time PCR Systems (Applied Biosystems).
The following programme was used: 50 C/2min; 95 C/10min; 40 cycles with
95 C/15 s; and 60 C/1min. Expression data were analysed using SDS 2.3 software
(Applied Biosystems) and the standard curve method of calculation. Mouse
cyclophilin A was used as an internal control gene. Primers used for the expression
studies are listed in Supplementary Table 3.
Fast-performance liquid chromatography. Plasma samples within each murine
or canine experimental group were pooled together and fractionated using the
fast-performance liquid chromatography (FPLC) method. All 50 fractions were
analysed to determine TC and TG content. Fractions containing LDL and
HDL were further analysed by immunoblot using anti-apoA1 (1:1,000) and
anti-apoB100 antibodies (1:1,000).
The TC distribution among the main lipoprotein classes of the individual
plasma samples was measured using FPLC analysis as described previously but
with some minor modiﬁcations53. In brief, the system contained a PU-980 ternary
pump with an LG-980-02 linear degasser and an UV-975 UV/VIS detector (Jasco).
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An extra PU 2080i-plus pump (Jasco) was used for in-line cholesterol ready-to-use
enzymatic reagent (Biomerieux) addition at a ﬂow rate of 0.1mlmin 1. EDTA
plasma was diluted 1:1 with Tris-buffered saline, and 30 ml sample buffer mixture
was loaded on a Superose 6 HR 10/30 column (GE Healthcare) for lipoprotein
separation at a ﬂow rate of 0.31mlmin 1. Chromatographic proﬁles of
commercially available plasma lipid standards (SKZL) served as reference.
Cell culture. Human embryonic kidney 293T cells (American Type Culture
Collection) and MEFs30,54 were cultured using Dulbecco’s Modiﬁed Eagles
Medium (DMEM) with Glutamax (GIBCO), supplemented with 10% fetal bovine
serum (Invitrogen) and antibiotics. Primary mouse hepatocytes were cultured in
DMEM—low glucose (GIBCO), supplemented with 5% fetal calf serum (FCS) or
normal calf lipoprotein-poor serum (NCLPPS) and antibiotics.
Sucrose gradients. Sucrose gradient separation of fractions obtained from fresh
liver tissue was performed as described before55 with few modiﬁcations. Chow-fed
mice were fasted for 4 h before killing. A unit of 200mg of liver was homogenated
in 800ml homogenization buffer (50mM Tris-HCl, ph 7.4, 250mM sucrose, 25mM
KCl, 5mM MgCl2, 3mM imidazole and protease inhibitor mixture) using a
Douncer homogenizer. Homogenates were centrifuged 1,000g, 10min at 4 C.
A unit of 300 mg liver homogenate was loaded on a 3.7-ml continuous 10–40%
sucrose gradient, and were centrifuged for 16 h using a Beckman Coulter
ultracentrifuge equipped with a swinging bucket rotor SW55 Ti, at 40,000 r.p.m.,
and fractions of 285ml were collected from the top of the tube; 1/10 of each fraction
was mixed with SDS sample buffer and used for immunoblot analysis.
Biotinylation assay. Culture of primary hepatocytes and biotinylation assay
were performed as previously described56. Cells were washed (3 ) with ice-cold
PBS-CM buffer (PBS, 1mM MgCl2 and 0.1mM CaCl2), subsequently 0.5mgml 1
biotin reagent solution (EZ-Link Sulfo-NHS-SS_Biotin, Thermo Scientiﬁc) in
biotinylation buffer (10mM triethanolamine, pH 8.0, 150mM NaCl and 2mM
CaCl2) was added to the cells for 30min at 4 C. Biotin reagent was removed and
cells were washed 1 with quenching buffer (PBS-CM, 25mM Tris-HCl, pH 7.4
and 192mM Glycine) for 30min at 4 C. Next, cells were washed 2 with
PBS-CM and 1 with TBS-C (50mM Tris-Cl, pH 7.4, 100mM NaCl and 2mM
CaCl2), and cells were collected by scraping in TBS-C. Cells were centrifuged
(1,000g, 5min, 4 C), lysed in biotin lysis buffer (50mM Tris-Cl, pH 7.4, 150mM
NaCl, 1% NP-40, 0.5% sodium deoxycholate, 5mM EDTA and 5mM EGTA),
sonicated (10% output for 10 s) and incubated on ice for 15min, subsequently
centrigufed for 15min at 12,000 g. Protein concentration was determined; 30 mg
was used as input; 300 mg was used diluted in biotin lysis buffer (500 ml); 30ml
Neutravidin beads (Neutravidin plus ultralink beads, Thermo Scientiﬁc) were
added and incubated for 4 h at 4 C. Beads were collected by centrifugation (500g,
5min), beads were washed 3 with Biotin lysis buffer, 1 with high-salt buffer
(50mM Tris-Cl, pH 7.4 and 500mM NaCl) and 1 with low-salt buffer (10mM
Tris-HCl). Finally the beads were resuspended in 30 ml 2 loading buffer.
Immunoprecipitation analysis. The glutathione S-transferase (GST) pull-down
assays and immunoprecipitation experiments were performed as described
before57. Cells were mainly lysed in NP-40 buffer (0.4M NaCl, 0.1% NP-40, 10mM
Tris-HCl, pH 8.0 and 1mM EDTA) supplemented with protease inhibitors.
Immunoprecipitation of the WASH complex and retromer was performed in MRB
lysis buffer (20mM HEPES pH 7.2, 50mM potassium acetate, 1mM EDTA,
200mM D-sorbitol and 0.1% Triton X-100) supplemented with protease inhibitors.
Equal amount of protein was used for immunoprecipiation and pull-down assays.
FLAG M2 agarose beads (Sigma-Aldrich) were used for Flag-immunoprecipitation
experiments, Glutathione Sepharose 4B (GE Healthcare Life Sciences) for GST
pull-down assays. Flag-, Ha-, GST-tagged proteins were detected by Flag-antibody
(F1804, Sigma, 1:2,000), Ha-antibody (clone HA-7, H6533, Sigma-Aldrich, 1:5,000)
and GST-antibody (sc-138, Santa Cruz, 1:5,000), respectively.
Dil-LDL uptake assay. Culture medium was replaced with DMEM culture
medium supplemented with Dil-LDL (5 mgml 1; Molecular Probes, Invitrogen).
Cells were kept for 1 h at 4 C, then for 5min at 37 C. Then they were immediately
placed on ice, washed with cold PBS and scraped. As a control for the speciﬁcity of
the investigated uptake pathway, cells were incubated with Alexa633-transferrin
(5mgml 1). Cells were centrifuged at 300g for 5min at 4 C and resuspended in
50ml of FACS buffer (PBS with 2% FCS and 5mM EDTA) supplemented with
additional 5% fetal bovine serum. Cell pellets were vortexed, and 2ml of FACS
buffer was added; samples were centrifuged as before and resuspended in 200 ml of
FACS buffer. Cells were kept on ice at all times and subjected to immediate FACS
analysis. The number of positive cells was counted and recorded as a percentage of
the whole population. Data of four independent experiments were presented
relative to the uptake results of the control WT population (set as 100%). Dil-LDL
uptake in MEFs determined by ﬂuorescence microscopy was performed with MEFs
cultured for 16 h in DMEM medium supplemented with lipoprotein-deﬁcient
serum (10%). Medium was changed with Dil-LDL (5 mgml 1) containing 5%
lipoprotein-deﬁcient serum/DMEM medium, and after 30min cells were ﬁxed and
mounted with Vectashield mounting medium with DAPI (Vector Laboratories).
Images were acquired with a Zeiss AxioObserver.Z1. Fluorescence intensity
was quantiﬁed using ImageJ software (National Institutes of Health) and was
normalized to the number of DAPI nuclei per image; 430 cells per condition
were recorded.
Statistical analysis. All results are expressed as a mean±s.e.m. Statistical analysis
was performed using Prism 5.00 for Windows (GraphPad Software) and the
unpaired Student’s t-test. Results of Po0.05 were considered statistically
signiﬁcant: *Po0.05, **Po0.01 and ***Po0.001.
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